EZH2 and cancer: Taken together, these results suggest that BMI1/RING1B degraders, such as MS147, but not the parent EED binder or EED/PRC2 degraders, can effectively suppress the proliferation of cancer cell lines that are insensitive to EZH2 knockout or EED/PRC2 degraders.